$2.42
-0.10 (-3.97%)
Open$2.45
Previous Close$2.52
Day High$2.66
Day Low$2.38
52W High$25.00
52W Low$2.38
Volume—
Avg Volume40.5K
Market Cap171.41M
P/E Ratio—
EPS$-1.14
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 466.5K | 122.20M | 119.09M |
| Net Income | -6,531,474 | 29.08M | 25.78M |
| Profit Margin | -1,392.6% | 23.8% | 21.7% |
| EBITDA | -4,130,659 | 41.35M | 38.15M |
| Free Cash Flow | — | 33.20M | 25.74M |
| Rev Growth | — | +2.9% | +5.6% |
| Debt/Equity | 0.01 | 0.45 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |